Skip to main content

Instructions

Student presentations must have a faculty sponsor.

Abstracts must include a title and a description of the research, scholarship, or creative work. The description should be 150-225 words in length and constructed in a format or style appropriate for the presenter’s discipline.

The following points should be addressed within the selected format or style for the abstract:

  • A clear statement of the problem or question you pursued, or the scholarly goal or creative theme achieved in your work.
  • A brief comment about the significance or uniqueness of the work.
  • A clear description of the methods used to achieve the purpose or goals for the work.
  • A statement of the conclusions, results, outcomes, or recommendations, or if the work is still in progress, the results you expect to report at the event.

Presenter photographs should be head and shoulder shots comparable to passport photos.

Additional Information

More information is available at carthage.edu/celebration-scholars/. The following are members of the Research, Scholarship, and Creativity Committee who are eager to listen to ideas and answer questions:

  • Jun Wang
  • Kim Instenes
  • John Kirk
  • Nora Nickels
  • Andrew Pustina
  • James Ripley

StarD6 and Alzheimer’s Disease: Identifying Potential Ligands and Binding Sites

Name: Danielle Koziczkowski
Major: Biology
Hometown: Grafton, WI
Faculty Sponsor:
Other Sponsors:  
Type of research: SURE
Funding: SURE

Abstract

Alzheimer’s Disease (AD) is a neurodegenerative condition that has become much more prevalent in the growing elderly population. This disease is caused by aggregation of beta-amyloid plaques and tau tangles. This inevitably leads to impaired cognitive function, and neuronal death. StarD6 is a steroidogenic acute regulatory protein and has been shown to possess neuroprotective properties. Patients with AD have decreased levels of StarD6 and elevated cholesterol levels. We are investigating possible ligands of StarD6 to see if cholesterol and other steroids associated with AD are able to bind to this transport protein, as well as which residues in the protein they bind to. 

$(function() { $('#print h2').prepend('Print'); $('#print h2 a').click(function() { window.print(); return false; }); });